364 related articles for article (PubMed ID: 25713027)
21. Stereochemistry and functions of the new cysteinyl-resolvin, 4S,5R-RCTR1, in efferocytosis and erythrophagocytosis of human senescent erythrocytes.
Nshimiyimana R; Libreros S; Simard M; Chiang N; Rodriguez AR; Spur BW; Haeggström JZ; Serhan CN
Am J Hematol; 2023 Jul; 98(7):1000-1016. PubMed ID: 37139907
[TBL] [Abstract][Full Text] [Related]
22. A newly synthesized 17-epi-NeuroProtectin D1/17-epi-Protectin D1: Authentication and functional regulation of Inflammation-Resolution.
Hamidzadeh K; Westcott J; Wourms N; Shay AE; Panigrahy A; Martin MJ; Nshimiyimana R; Serhan CN
Biochem Pharmacol; 2022 Sep; 203():115181. PubMed ID: 35850309
[TBL] [Abstract][Full Text] [Related]
23. A one-step method of 10,17-dihydro(pero)xydocosahexa-4Z,7Z,11E,13Z,15E,19Z-enoic acid synthesis by soybean lipoxygenase.
Butovich IA
J Lipid Res; 2006 Apr; 47(4):854-63. PubMed ID: 16391324
[TBL] [Abstract][Full Text] [Related]
24. Full characterization of PDX, a neuroprotectin/protectin D1 isomer, which inhibits blood platelet aggregation.
Chen P; Fenet B; Michaud S; Tomczyk N; Véricel E; Lagarde M; Guichardant M
FEBS Lett; 2009 Nov; 583(21):3478-84. PubMed ID: 19818771
[TBL] [Abstract][Full Text] [Related]
25. Infection regulates pro-resolving mediators that lower antibiotic requirements.
Chiang N; Fredman G; Bäckhed F; Oh SF; Vickery T; Schmidt BA; Serhan CN
Nature; 2012 Apr; 484(7395):524-8. PubMed ID: 22538616
[TBL] [Abstract][Full Text] [Related]
26. Metabolism and biological production of resolvins derived from docosapentaenoic acid (DPAn-6).
Dangi B; Obeng M; Nauroth JM; Chung G; Bailey-Hall E; Hallenbeck T; Arterburn LM
Biochem Pharmacol; 2010 Jan; 79(2):251-60. PubMed ID: 19679107
[TBL] [Abstract][Full Text] [Related]
27. On the structure and synthesis of neuroprotectin D1, a novel anti-inflammatory compound of the docosahexaenoic acid family.
Butovich IA
J Lipid Res; 2005 Nov; 46(11):2311-4. PubMed ID: 16150835
[TBL] [Abstract][Full Text] [Related]
28. Resolvin D1 and resolvin D2 govern local inflammatory tone in obese fat.
Clària J; Dalli J; Yacoubian S; Gao F; Serhan CN
J Immunol; 2012 Sep; 189(5):2597-605. PubMed ID: 22844113
[TBL] [Abstract][Full Text] [Related]
29. Dabigatran activates inflammation resolution by promoting fibrinogen-like protein 2 shedding and RvD5
Lei J; Zhou Y; Zhao H; Chen Y; Yan G; Wu L; Xu Y; Zhang J; Zhang X; Wang J; Li D; Li Y
Theranostics; 2021; 11(9):4251-4261. PubMed ID: 33754059
[No Abstract] [Full Text] [Related]
30. Identification of 14,20-dihydroxy-docosahexaenoic acid as a novel anti-inflammatory metabolite.
Yokokura Y; Isobe Y; Matsueda S; Iwamoto R; Goto T; Yoshioka T; Urabe D; Inoue M; Arai H; Arita M
J Biochem; 2014 Dec; 156(6):315-21. PubMed ID: 25012818
[TBL] [Abstract][Full Text] [Related]
31. Quantitative analysis of chemoresistance-inducing fatty acid in food supplements using UHPLC-ESI-MS/MS.
Schlotterbeck J; Cebo M; Kolb A; Lämmerhofer M
Anal Bioanal Chem; 2019 Jan; 411(2):479-491. PubMed ID: 30460390
[TBL] [Abstract][Full Text] [Related]
32. Novel n-3 immunoresolvents: structures and actions.
Dalli J; Colas RA; Serhan CN
Sci Rep; 2013; 3():1940. PubMed ID: 23736886
[TBL] [Abstract][Full Text] [Related]
33. Resolvin E1 and protectin D1 activate inflammation-resolution programmes.
Schwab JM; Chiang N; Arita M; Serhan CN
Nature; 2007 Jun; 447(7146):869-74. PubMed ID: 17568749
[TBL] [Abstract][Full Text] [Related]
34. Maresin biosynthesis and identification of maresin 2, a new anti-inflammatory and pro-resolving mediator from human macrophages.
Deng B; Wang CW; Arnardottir HH; Li Y; Cheng CY; Dalli J; Serhan CN
PLoS One; 2014; 9(7):e102362. PubMed ID: 25036362
[TBL] [Abstract][Full Text] [Related]
35. Insights in diabetes: Molecular mechanisms-Protectin DX, an anti-inflammatory and a stimulator of inflammation resolution metabolite of docosahexaenoic acid, protects against the development of streptozotocin-induced type 1 and type 2 diabetes mellitus in male Swiss albino mice.
Rengachar P; Polavarapu S; Das UN
Front Endocrinol (Lausanne); 2022; 13():1053879. PubMed ID: 36778598
[TBL] [Abstract][Full Text] [Related]
36. Efficient biotransformation of docosahexaenoic acid-rich oils into the lipid mediator resolvin D5 by cells expressing 15S-lipoxygenase using a bioreactor.
Lee J; Park HA; Shin KC; Park JB; Oh DK
Bioresour Technol; 2023 Nov; 388():129750. PubMed ID: 37717704
[TBL] [Abstract][Full Text] [Related]
37. Resolvin D2 is a potent regulator of leukocytes and controls microbial sepsis.
Spite M; Norling LV; Summers L; Yang R; Cooper D; Petasis NA; Flower RJ; Perretti M; Serhan CN
Nature; 2009 Oct; 461(7268):1287-91. PubMed ID: 19865173
[TBL] [Abstract][Full Text] [Related]
38. New maresin conjugates in tissue regeneration pathway counters leukotriene D
Chiang N; Riley IR; Dalli J; Rodriguez AR; Spur BW; Serhan CN
FASEB J; 2018 Jul; 32(7):4043-4052. PubMed ID: 29490167
[TBL] [Abstract][Full Text] [Related]
39. Aspirin-triggered resolvin D1 reduces mucosal inflammation and promotes resolution in a murine model of acute lung injury.
Eickmeier O; Seki H; Haworth O; Hilberath JN; Gao F; Uddin M; Croze RH; Carlo T; Pfeffer MA; Levy BD
Mucosal Immunol; 2013 Mar; 6(2):256-66. PubMed ID: 22785226
[TBL] [Abstract][Full Text] [Related]
40. The precursor of resolvin D series and aspirin-triggered resolvin D1 display anti-hyperalgesic properties in adjuvant-induced arthritis in rats.
Lima-Garcia JF; Dutra RC; da Silva K; Motta EM; Campos MM; Calixto JB
Br J Pharmacol; 2011 Sep; 164(2):278-93. PubMed ID: 21418187
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
